These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7414236)

  • 21. Modification of bile acids by intestinal bacteria.
    Lewis R; Gorbach S
    Arch Intern Med; 1972 Oct; 130(4):545-9. PubMed ID: 4562151
    [No Abstract]   [Full Text] [Related]  

  • 22. Bile-salt deconjugation and steatorrhoea in patients with the stagnant-loop syndrome.
    Tabaqchali S; Hatzioannou J; Booth CC
    Lancet; 1968 Jul; 2(7558):12-6. PubMed ID: 4172682
    [No Abstract]   [Full Text] [Related]  

  • 23. [Distribution of intestinal dysbacteriosis among children].
    Krivogorskiĭ EB; Meshcherekova KM; Malkina RD; Mikitina RV
    Vopr Okhr Materin Det; 1974 May; 19(5):89. PubMed ID: 4464651
    [No Abstract]   [Full Text] [Related]  

  • 24. [The efficacy of using an immune lactoglobulin preparation for correcting intestinal dysbacteriosis in newborn infants].
    Kushnareva MV; Keshishian ES; Soboleva SV
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (2):101-4. PubMed ID: 7653120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rapid diagnosis of dysbacteriosis by detecting beta-aspartylglycine in the feces in an experiment].
    Chakhava OV; Ruban SZ; Shustrova NM; Iur'eva EA
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Aug; (8):15-8. PubMed ID: 4060948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The possibilities for correcting the dysbacteriosis occurring in the prolonged external diversion of bile].
    Shor-Chudnovskiĭ ME; Susak IaM; Grigor'ev AV; Kurik MV; Shelkovaia NG
    Klin Khir (1962); 1993; (11):30-2. PubMed ID: 8207906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical trial of norfloxacin in the treatment of bacterial enteritis.
    Cristiano P
    J Chemother; 1989 Jul; 1(4 Suppl):833-4. PubMed ID: 16312660
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of various diseases complicated by dysbacteriosis of the intestines].
    Krasnogolovets VN
    Klin Med (Mosk); 1970 May; 48(5):54-9. PubMed ID: 4915000
    [No Abstract]   [Full Text] [Related]  

  • 29. [Intestinal dysbacteriosis in yersiniosis patients and the possibility of its correction with biopreparations].
    Kuznetsov VF; Iushchuk ND; Iurko LP; Nabokova NIu
    Ter Arkh; 1994; 66(11):17-8. PubMed ID: 7900004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Modern aspects of the normal state and pathology of intestinal microflora (a review of the literature)].
    Lebedeva MN; Goncharova GI; Liz'ko NN
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Sep; (9):36-41. PubMed ID: 4613083
    [No Abstract]   [Full Text] [Related]  

  • 31. [Intestinal diseases and intestinal microbial flora].
    Alés Reinlein JM; Marina Fiol C
    Rev Clin Esp; 1969 Sep; 114(6):541-8. PubMed ID: 4915698
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections.
    Bradford PA; Weaver-Sands DT; Petersen PJ
    Clin Infect Dis; 2005 Sep; 41 Suppl 5():S315-32. PubMed ID: 16080070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Empiric antibacterial therapy of acute intestinal infections in children (manual for physicians)].
    Gorelov AV; Maleev VV; Miliutina LN; Vorotyntseva NV; ;
    Antibiot Khimioter; 2001; 46(10):19-24. PubMed ID: 11881189
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug therapy of a group of germ-caused or germ-maintained diseases of the small and large intestine].
    Germer WD
    Dtsch Med J; 1972 Apr; 23(4):280-5. PubMed ID: 5044183
    [No Abstract]   [Full Text] [Related]  

  • 35. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data.
    Babinchak T; Ellis-Grosse E; Dartois N; Rose GM; Loh E; ;
    Clin Infect Dis; 2005 Sep; 41 Suppl 5():S354-67. PubMed ID: 16080073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intestinal microflora in irradiated mice with enteral administration of poorly adsorbed antibiotics].
    Khanykov AV; Nasonova TA; Nevinnaia AP; Tiurin EA; Strel'nikov VA
    Radiobiologiia; 1982; 22(2):280-3. PubMed ID: 7089220
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapy of diseases of the small intestine].
    Kasper H; Schultis K
    Med Welt; 1969 Dec; 51():2777-9. PubMed ID: 5373745
    [No Abstract]   [Full Text] [Related]  

  • 38. [Infected bowel syndrome].
    Campanozzi A; Borrelli O; Salvia G; Ciccimarra E; Alfieri E; Calabrese F; Cucchiara S
    Pediatr Med Chir; 1995; 17(6):493-7. PubMed ID: 8668582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early presumptive antibacterial therapy for potentially fatal infections in surgical patients with intestinal diseases.
    McHenry MC; Turnbull RB
    Proc R Soc Med; 1970; 63 Suppl(Suppl 1):25-8. PubMed ID: 5525494
    [No Abstract]   [Full Text] [Related]  

  • 40. [Diagnostic use of serological studies in intestinal bacterial diseases and other bacterial infections].
    Tønder O
    Tidsskr Nor Laegeforen; 1983 Jan; 103(3):196-8. PubMed ID: 6845318
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.